News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Two-for-one molecule could target two key drivers of aggressive childhood cancer
A group of molecules which each simultaneously target two of the most common genetic faults behind an aggressive form of childhood cancer could lead to a potential new drug for the disease, a new ICR study suggests.
New panel of genes identifies men at highest risk of aggressive prostate cancer
A new panel of genes could pick out men at highest risk of developing prostate cancer and pick out those already diagnosed who are likely to have particularly aggressive forms of the disease, a large-scale genetic analysis has found.
Manifesto calls for action on cancer drug access as survey shows patient delays
Our new 10-point manifesto is calling for action to speed up access to innovative cancer drugs as an accompanying survey of 1,000 cancer patients finds many face barriers in receiving the latest treatments.
Targeted breast cancer drug – olaparib – given green light by EU
European Medicines Agency approves olaparib for women with BRCA-mutant breast cancer – 15 months after licensing in the US.
Cancers ‘change spots’ to avoid immunotherapy
Cancers can make themselves harder for new immunotherapies to see by ‘changing their spots’ – and switching off a key molecule on the surface of cells that is otherwise recognised by treatment.
Three-pronged attack can overcome drug resistance in bowel cancer
Researchers at the ICR show that triple drug combinations could prevent resistance in many cancer types.
Sutton MP – Paul Scully – becomes cancer researcher for the day at the ICR
Local MP Paul Scully donned a lab coat and safety specs to spend a day as a cancer researcher working in the Sutton laboratories of the ICR.
ICR researchers among the world’s most influential
Researchers at the ICR and The Royal Marsden have been named in a list of the world's most influential researchers.
Discovery Club members meet next generation of cancer researchers
A number of up-and-coming cancer researchers from the ICR shared the research challenges they are working on to outsmart cancer at our latest Discovery Club event.
3D printed tungsten could improve gamma camera images
A honeycomb of tungsten built using 3D printing could help take better quality images of processes inside the body, a new study shows.
New version of canSAR database is more user-friendly, with more data than ever before
The world’s largest and most comprehensive resource for cancer drug discovery has been updated to include more data and new tools to make it easier to use than ever before.
Precision drugs could unmask cancers to the immune system and boost the effects of immunotherapy
Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals.
